Logo image
Mouse hepatitis virus
Journal article   Open access   Peer reviewed

Mouse hepatitis virus

Jodie Haring and Stanley Perlman
Current Opinion in Microbiology, Vol.4(4), pp.462-466
2001
DOI: 10.1016/S1369-5274(00)00236-8
PMID: 11495812
url
https://doi.org/10.1016/S1369-5274(00)00236-8View
Published (Version of record) Open Access

Abstract

Inoculation of mice with most neurotropic strains of the coronavirus mouse hepatitis virus results in an immune response-mediated demyelinating disease that serves as an excellent animal model for the human disease multiple sclerosis. Recent work has shown that either virus-specific CD4 + or CD8 + T cells are able to mediate demyelination and also that the antibody response is crucial for clearing infectious virus. Another exciting advance is the development of recombinant coronaviruses, which, for the first time, will allow genetic manipulation of the entire viral genome.
targeted recombination coronavirus reverse genetics mouse hepatitis virus demyelination central nervous system

Details

Metrics

Logo image